Statistics for IO Biotech, Inc. (id:8414 IOBT)
Valuation metrics
Market cap
63.91M
Enterprise value
-34,685,924.00
Trailing P/E (ttm)
-0.41
Forward P/E
-0.83
PEG ratio
-0.83
Price/Sales (ttm)
Price/Book (mrq)
0.66
Enterprise Value/Revenue
Enterprise Value/EBITDA
0.37
Overview
Shares outstanding
65.88M
Float
27.84M
Shares short
200.92K
% Held by insiders
0.00%
% Held by institutions
0.77%
Average volume (10 days)
450.36K
Average volume (90 days)
Price summary
52-Week low
0.73
52-Week high
2.10
52-Week change
-42.51%
Beta
0.42
50-Day moving average
1.09
200-Day moving average
1.37
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
June 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-50.98%
Return on equity
-87.66%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-93,157,000.00
Net income to common (ttm)
-88,004,000.00
Diluted EPS (ttm)
-1.26
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
100.75M
Total cash per share (mrq)
1.53
Total debt (mrq)
2.15M
Total Debt/Equity (mrq)
2.23
Current ratio (mrq)
784.50%
Book value per share (mrq)
1.46
Cash flow
Cash flow statement
-80,699,000.00
Levered free cash flow (LFCF)
-51,137,124.00